{"id":19505,"date":"2023-01-31T11:01:41","date_gmt":"2023-01-31T11:01:41","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/uk\/?page_id=19505"},"modified":"2026-06-09T07:24:40","modified_gmt":"2026-06-09T07:24:40","slug":"charles-morris","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/executive-committee\/charles-morris\/","title":{"rendered":"CHARLES MORRIS"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"19505\" class=\"elementor elementor-19505\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-216808a elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"216808a\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;4c9dcae&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2ce007b\" data-id=\"2ce007b\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ceb8f37 elementor-widget elementor-widget-text-editor\" data-id=\"ceb8f37\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-28196773 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"28196773\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;f02b98c&quot;,&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-3f619717\" data-id=\"3f619717\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-78c77542 elementor-widget elementor-widget-image\" data-id=\"78c77542\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"716\" height=\"700\" src=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2023\/03\/27105443\/charles-morris.jpg\" class=\"attachment-full size-full wp-image-19604\" alt=\"\" srcset=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2023\/03\/27105443\/charles-morris.jpg 716w, https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2023\/03\/27105443\/charles-morris-300x293.jpg 300w, https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2023\/03\/27105443\/charles-morris-600x587.jpg 600w\" sizes=\"(max-width: 716px) 100vw, 716px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-7244178b elementor-section-content-top elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7244178b\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;5f899ce&quot;,&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-7317f839\" data-id=\"7317f839\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-26e48976 elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"26e48976\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"fab fa-linkedin-in\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-10f3363a\" data-id=\"10f3363a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7d302d2f elementor-widget elementor-widget-heading\" data-id=\"7d302d2f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<p class=\"elementor-heading-title elementor-size-default\"><a href=\"https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/\" target=\"_blank\">https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/<\/a><\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-66 elementor-top-column elementor-element elementor-element-7a080520\" data-id=\"7a080520\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3ea58033 elementor-widget elementor-widget-jet-breadcrumbs\" data-id=\"3ea58033\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"jet-breadcrumbs.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-jet-breadcrumbs jet-blocks\">\n\t\t<div class=\"jet-breadcrumbs\">\n\t\t<div class=\"jet-breadcrumbs__content\">\n\t\t<div class=\"jet-breadcrumbs__wrap\"><div class=\"jet-breadcrumbs__item\"><a href=\"https:\/\/www.neuraxpharm.com\/uk\/\" class=\"jet-breadcrumbs__item-link is-home\" rel=\"home\" title=\"Neuraxpharm\">Neuraxpharm<\/a><\/div>\n\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4988b078 elementor-widget elementor-widget-heading\" data-id=\"4988b078\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Charles Morris<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2a64c3da elementor-widget elementor-widget-text-editor\" data-id=\"2a64c3da\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Charles Morris is Chief Corporate Development Officer and joined Neuraxpharm in January 2022. Charles is a seasoned M&amp;A professional with 20 years of experience in investment banking and corporate M&amp;A in the pharmaceutical industry, across multiple geographies, including the US, Germany and Spain.<\/p><p>Before joining Neuraxpharm, Charles was Global Head of M&amp;A and Corporate Development at Almirall (2019-2021) and prior to this he was Vice President, Head of M&amp;A, Pharma General Medicine &amp; Animal Health at Bayer AG (2010-2019). Earlier in his career, Charles worked in investment banking and equity research for Bank of America, Merrill Lynch and Molecular Securities in New York.<\/p><p>Charles holds an MBA from Columbia Business School (USA) and an undergraduate degree in Economics and Political Science from Emory University (USA).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-56df7274 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"56df7274\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;_id&quot;:&quot;e7d9f21&quot;,&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5fa6908a\" data-id=\"5fa6908a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fdc0c5d elementor-widget elementor-widget-spacer\" data-id=\"fdc0c5d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business https:\/\/www.linkedin.com\/in\/charles-morris-35b52035\/ Neuraxpharm Charles Morris Charles Morris is Chief Corporate Development Officer and joined Neuraxpharm in January 2022. Charles is a seasoned M&amp;A professional with 20 years of experience in investment banking and corporate M&amp;A in the pharmaceutical [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":19514,"parent":1998,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-19505","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Charles Morris - Neuraxpharm<\/title>\n<meta name=\"description\" content=\"Learn about Charles Morris, Head of M&amp;A at Neuraxpharm UK, his extensive pharma M&amp;A background, and his role in the company.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CHARLES MORRIS\" \/>\n<meta property=\"og:description\" content=\"Learn about Charles Morris, Head of M&amp;A at Neuraxpharm UK, his extensive pharma M&amp;A background, and his role in the company.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-09T07:24:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2021\/03\/31110303\/charles-morris-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"716\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/executive-committee\\\/charles-morris\\\/\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/about-us\\\/executive-committee\\\/ana-apezteguia\",\"name\":\"Charles Morris - Neuraxpharm\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/about-us\\\/executive-committee\\\/ana-apezteguia#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/about-us\\\/executive-committee\\\/ana-apezteguia#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/static.neuraxpharm.com\\\/wp-content\\\/uploads\\\/sites\\\/19\\\/2021\\\/03\\\/31110303\\\/charles-morris-1.png\",\"datePublished\":\"2023-01-31T11:01:41+00:00\",\"dateModified\":\"2026-06-09T07:24:40+00:00\",\"description\":\"Learn about Charles Morris, Head of M&A at Neuraxpharm UK, his extensive pharma M&A background, and his role in the company.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/about-us\\\/executive-committee\\\/ana-apezteguia#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.neuraxpharm.com\\\/about-us\\\/executive-committee\\\/ana-apezteguia\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/about-us\\\/executive-committee\\\/ana-apezteguia#primaryimage\",\"url\":\"https:\\\/\\\/static.neuraxpharm.com\\\/wp-content\\\/uploads\\\/sites\\\/19\\\/2021\\\/03\\\/31110303\\\/charles-morris-1.png\",\"contentUrl\":\"https:\\\/\\\/static.neuraxpharm.com\\\/wp-content\\\/uploads\\\/sites\\\/19\\\/2021\\\/03\\\/31110303\\\/charles-morris-1.png\",\"width\":716,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/about-us\\\/executive-committee\\\/ana-apezteguia#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"About Neuraxpharm\",\"item\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Executive Committee\",\"item\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/executive-committee\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CHARLES MORRIS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/#website\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/\",\"name\":\"Neuraxpharm\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Charles Morris - Neuraxpharm","description":"Learn about Charles Morris, Head of M&A at Neuraxpharm UK, his extensive pharma M&A background, and his role in the company.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia","og_locale":"en_US","og_type":"article","og_title":"CHARLES MORRIS","og_description":"Learn about Charles Morris, Head of M&A at Neuraxpharm UK, his extensive pharma M&A background, and his role in the company.","og_url":"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia","og_site_name":"Neuraxpharm","article_modified_time":"2026-06-09T07:24:40+00:00","og_image":[{"width":716,"height":700,"url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2021\/03\/31110303\/charles-morris-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/executive-committee\/charles-morris\/","url":"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia","name":"Charles Morris - Neuraxpharm","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia#primaryimage"},"image":{"@id":"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia#primaryimage"},"thumbnailUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2021\/03\/31110303\/charles-morris-1.png","datePublished":"2023-01-31T11:01:41+00:00","dateModified":"2026-06-09T07:24:40+00:00","description":"Learn about Charles Morris, Head of M&A at Neuraxpharm UK, his extensive pharma M&A background, and his role in the company.","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia#primaryimage","url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2021\/03\/31110303\/charles-morris-1.png","contentUrl":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2021\/03\/31110303\/charles-morris-1.png","width":716,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/about-us\/executive-committee\/ana-apezteguia#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"About Neuraxpharm","item":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/"},{"@type":"ListItem","position":2,"name":"Executive Committee","item":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/executive-committee\/"},{"@type":"ListItem","position":3,"name":"CHARLES MORRIS"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/uk\/#website","url":"https:\/\/www.neuraxpharm.com\/uk\/","name":"Neuraxpharm","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages\/19505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/comments?post=19505"}],"version-history":[{"count":14,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages\/19505\/revisions"}],"predecessor-version":[{"id":21257,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages\/19505\/revisions\/21257"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages\/1998"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/media\/19514"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/media?parent=19505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}